Synovitis and joint health in patients with haemophilia: Statements from a European e-Delphi consensus study.
Delphi consensus
haemophilia
joint health
point-of-care ultrasound
synovitis
Journal
Haemophilia : the official journal of the World Federation of Hemophilia
ISSN: 1365-2516
Titre abrégé: Haemophilia
Pays: England
ID NLM: 9442916
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
revised:
01
12
2022
received:
06
09
2022
accepted:
14
12
2022
pubmed:
10
1
2023
medline:
21
3
2023
entrez:
9
1
2023
Statut:
ppublish
Résumé
Synovitis, a common feature in haemophilia, is triggered by the presence of blood in joints, and represents the first step towards the development of chronic arthropathy. Synovitis may be detected early by means of ultrasound or magnetic resonance imaging scan; clinical joint scores are less sensitive in this setting. Regular long-term prophylaxis with clotting factor concentrates, as primary prophylaxis and tailored to individual needs, has high efficacy in preventing synovitis. In general, higher factor levels lower bleeding risk, but no direct correlation between factor levels and synovitis incidence has been demonstrated. This study aimed to develop an expert consensus relating to the definition, pathophysiology, diagnosis, prevention, follow-up and treatment of synovitis, recognising its relevance for joint health and taking into account existing knowledge gaps. A Delphi consensus study was designed and performed. An expert group prepared 22 statements based on existing literature; a wider expert panel subsequently voted on these. Retention of panellists was high. Four statements required amending and consensus on all statements was achieved after three rounds of voting. This e-Delphi consensus study addressed the importance of synovitis in joint health of people with haemophilia and highlighted knowledge gaps in this field. Studies on the natural course of synovitis are lacking and the biological mechanisms underlying this process are not yet fully elucidated. While basic and clinical research proceeds in this field, expert consensus can help guide clinicians in their routine clinical practice, and Delphi methodology is often used to produce best-practice guidelines.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
619-628Subventions
Organisme : Swedish Orphan Biovitrum
Informations de copyright
© 2023 The Authors. Haemophilia published by John Wiley & Sons Ltd.
Références
van Vulpen LFD, Thomas S, Keny SA, Mohanty SS. Synovitis and synovectomy in haemophilia. Haemophilia. 2021;27(Suppl 3):96-102.
van Vulpen LF, van Meegeren ME, Roosendaal G, et al. Biochemical markers of joint tissue damage increase shortly after a joint bleed; an explorative human and canine in vivo study. Osteoarthritis Cartilage. 2015;23:63-69.
Hilliard P, Funk S, Zourikian N, et al. Hemophilia joint health score reliability study. Haemophilia. 2006;12:518-525.
Seuser A, Bohm P, Wermes C. Early orthopaedic challenges in haemophilia patients and therapeutic approach. Thromb Res. 2014;134(Suppl 1):S61-67.
Doria AS, Lundin B, Kilcoyne RF, et al. Reliability of progressive and additive MRI scoring systems for evaluation of haemophilic arthropathy in children: expert MRI Working Group of the International Prophylaxis Study Group. Haemophilia. 2005;11:245-253.
Doria AS, Babyn PS, Lundin B, et al. Reliability and construct validity of the compatible MRI scoring system for evaluation of haemophilic knees and ankles of haemophilic children. Expert MRI working group of the international prophylaxis study group. Haemophilia. 2006;12:503-513.
Doria AS, Lundin B, Miller S, et al. Reliability and construct validity of the compatible MRI scoring system for evaluation of elbows in haemophilic children. Haemophilia. 2008;14:303-314.
Lundin B, Manco-Johnson ML, Ignas DM, et al. An MRI scale for assessment of haemophilic arthropathy from the International Prophylaxis Study Group. Haemophilia. 2012;18:962-970.
Doria AS. State-of-the-art imaging techniques for the evaluation of haemophilic arthropathy: present and future. Haemophilia. 2010;16(Suppl 5):107-114.
van Vulpen LFD, Holstein K, Martinoli C. Joint disease in haemophilia: pathophysiology, pain and imaging. Haemophilia. 2018;24(Suppl 6):44-49.
Martinoli C, Della Casa Alberighi O, Di Minno G, et al. Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US). Thromb Haemost. 2013;109:1170-1179.
Volland LM, Zhou JY, Barnes RFW, et al. Development and reliability of the joint tissue activity and damage examination for quantitation of structural abnormalities by musculoskeletal ultrasound in hemophilic joints. J Ultrasound Med. 2019;38:1569-1581.
Hermans C, Noone D, Benson G, et al. Hemophilia treatment in 2021: choosing the“optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. Blood Rev. 2022;52:100890.
Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the Management of Hemophilia panelists and co-authors. Haemophilia. 2020;26(Suppl 6):1-158. WFH Guidelines for the Management of Hemophilia, 3rd edition.
Collins PW, Blanchette VS, Fischer K, et al. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. J Thromb Haemost. 2009;7:413-420.
Chalmers J, Armour M. The Delphi technique. In: Liamputtong P, ed. Handbook of research methods in health social sciences. Springer Nature Singapore Pte Ltd; 2019:715-735. doi:10.1007/978-981-10-5251-4_99
Humphrey-Murto S, Wood TJ, Gonsalves C, Mascioli K, Varpio L. The Delphi Method. Acad Med. 2020;95:168.
Boddenberg-Pätzold B, Brackmann HH, Habermann B, et al. Accessed 04 July 2022. https://www.awmf.org/uploads/tx_szleitlinien/086-005l_S2k_Synovitis-bei-Haemophilie_2019-07.pdf
Humphrey-Murto S, Varpio L, Gonsalves C, Wood TJ. Using consensus group methods such as Delphi and Nominal Group in medical education research. Med Teach. 2017;39:14-19.
Hanley J, McKernan A, Creagh MD, et al. Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: a United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) guideline. Haemophilia. 2017;23:511-520.
Di Minno MND, Napolitano M, Giuffrida AC, et al. Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres. Br J Haematol. 2022;196:871-883.
Roosendaal G, Vianen ME, Wenting MJ, et al. Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. J Bone Joint Surg Br. 1998;80:540-545.
Wojdasiewicz P, Poniatowski ŁA, Nauman P, et al. Cytokines in the pathogenesis of hemophilic arthropathy. Cytokine Growth Factor Rev. 2018;39:71-91.
Pulles AE, Mastbergen SC, Schutgens RE, Lafeber FP, van Vulpen LF. Pathophysiology of hemophilic arthropathy and potential targets for therapy. Pharmacol Res. 2017;115:192-199.
Hakobyan N, Enockson C, Cole AA, Sumner DR, Valentino LA. Experimental haemophilic arthropathy in a mouse model of a massive haemarthrosis: gross, radiological and histological changes. Haemophilia. 2008;14:804-809.
Hooiveld MJ, Roosendaal G, Vianen ME, van den Berg HM, Bijlsma JW, Lafeber FP. Immature articular cartilage is more susceptible to blood-induced damage than mature articular cartilage: an in vivo animal study. Arthritis Rheum. 2003;48:396-403.
Morris CJ, Blake DR, Wainwright AC, Steven MM. Relationship between iron deposits and tissue damage in the synovium: an ultrastructural study. Ann Rheum Dis. 1986;45:21-26.
Ovlisen K, Kristensen AT, Jensen AL, Tranholm M. IL-1 beta, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis. Haemophilia. 2009;15:802-810.
Roosendaal G, TeKoppele JM, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: a canine in vivo study. Arthritis Rheum. 1999;42:1033-1039.
Roosendaal G, Vianen ME, Marx JJ, van den Berg HM, Lafeber FP, Bijlsma JW. Blood induced joint damage: a human in vitro study. Arthritis Rheum. 1999;42:1025-1032.
Sen D, Chapla A, Walter N, Daniel V, Srivastava A, Jayandharan GR. Nuclear factor (NF)- kappaB and its associated pathways are major molecular regulators of blood-induced joint damage in a murine model of hemophilia. J Thromb Haemost. 2013;11:293-306.
Tajima T, Yoshida E, Yamashita A, et al. Hemoglobin stimulates the expression of matrix metalloproteinases, MMP-2 and MMP-9 by synovial cells: a possible cause of joint damage after intra-articular hemorrhage. J Orthop Res. 2005;23:891-898.
van Vulpen LF, Schutgens RE, Coeleveld K, et al. IL- 1beta, in contrast to TNFalpha, is pivotal in blood-induced cartilage damage and is a potential target for therapy. Blood. 2015;126:2239-2246.
Krüger S, Hoffmeister M, Hilberg T. Pain and structural alterations in knee joints in patients with haemophilia. Haemophilia. 2018;24:657-666.
Querol F. Sequelae of repeated lesions in persons with hemophilia. Blood Coagul Fibrinolysis. 2019;30:S7-10.
Kuijlaars IAR, Timmer MA, de Kleijn P, Pisters MF, Fischer K. Monitoring joint health in haemophilia: factors associated with deterioration. Haemophilia. 2017;23:934-940.
Bakeer N, Dover S, Babyn P, et al. Musculoskeletal ultrasound in hemophilia: results and recommendations from a global survey and consensus meeting. Res Pract Thromb Haemost. 2021;5:e12531.
van Vulpen LFD, Mastbergen SC, Lafeber FPJG, Schutgens REG. Differential effects of bleeds on the development of arthropathy - basic and applied issues. Haemophilia. 2017;23:521-527.
Jansen NW, Roosendaal G, Bijlsma JW, Degroot J, Lafeber FP. Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: an in vitro study. Arthritis Rheum. 2007;56:199-207.
Jansen NW, Roosendaal G, Wenting MJ, et al. Very rapid clearance after a joint bleed in the canine knee cannot prevent adverse effects on cartilage and synovial tissue. Osteoarthritis Cartilage. 2009;17:433-440.
Madhok R, Bennett D, Sturrock RD, Forbes CD. Mechanisms of joint damage in an experimental model of hemophilic arthritis. Arthritis Rheum. 1988;31:1148-1155.
Roosendaal G, Jansen NW, Schutgens R, Lafeber FP. Haemophilic arthropathy: the importance of the earliest haemarthroses and consequences for treatment. Haemophilia. 2008;14(Suppl 6):4-10.
Valentino LA, Hakobyan N, Rodriguez N, Hoots WK. Pathogenesis of haemophilic synovitis: experimental studies on blood-induced joint damage. Haemophilia. 2007;13(Suppl 3):10-13.
Puetz J. Nano-evidence for joint microbleeds in hemophilia patients. J Thromb Haemost. 2018;16:1914-1917.
Wharton R, Austin S, Back D. Subchondral haematoma. The missing link in understanding haemophilic arthropathy? Hamostaseologie. 2017;37:104-106.
Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357:535-544.
Olivieri M, Kurnik K, Pfluger T, Bidlingmaier C. Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis. Haemophilia. 2012;18:369-374.
De la Corte-Rodriguez H, Rodriguez-Merchan EC, Alvarez-Roman MT, Martin-Salces M, Martinoli C, Jimenez-Yuste V. The value of HEAD-US system in detecting subclinical abnormalities in joints of patients with hemophilia. Expert Rev Hematol. 2018;11:253-261.
Seuser A, Kurnik K, Mahlein AK. Infrared thermography as a non-invasive tool to explore differences in the musculoskeletal system of children with hemophilia compared to an age-matched healthy group. Sensors (Basel). 2018;18:518.
Bakeer N, Shapiro AD. Merging into the mainstream: the evolution of the role of point-of-care musculoskeletal ultrasound in hemophilia. 2019. doi: 10.12688/f1000research.16039.1. Jul 9;8:F1000 Faculty Rev-1029. eCollection 2019.
Aznar JA, Abad-Franch L, Perez-Alenda S, Haya S, Cid AR, Querol F. Ultrasonography in the monitoring of management of haemarthrosis. Haemophilia. 2011;17:826-828.
Kidder W, Nguyen S, Larios J, Bergstrom J, Ceponis A, von Drygalski A. Point-of-care musculoskeletal ultrasound is critical for the diagnosis of hemarthroses, inflammation and soft tissue abnormalities in adult patients with painful haemophilic arthropathy. Haemophilia. 2015;21:530-537.
Klukowska A, Czyrny Z, Laguna P, Brzewski M, Serafin-Krol MA, Rokicka-Milewska R. Correlation between clinical, radiological and ultrasonographical image of knee joints in children with haemophilia. Haemophilia. 2001;7:286-292.
De la Corte-Rodriguez H, Rodriguez-Merchan EC, Alvarez-Roman MT, Martin-Salces M, Jimenez-Yuste V. Clinical assessment and point of care ultrasonography: how to diagnose haemophilic synovitis. Haemophilia. 2022;28:138-144.
Ling M, Heysen JP, Duncan EM, Rodgers SE, Lloyd JV. High incidence of ankle arthropathy in mild and moderate haemophilia A. Thromb Haemost. 2011;105:261-268.
Scott MJ, Xiang H, Hart DP, et al. Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: the THUNDER study. Haemophilia. 2019;25:205-212.
Oldenburg J. Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens. Blood. 2015;125:2038-2044.
Collins PW, Obaji SG, Roberts H, Gorsani D, Rayment R. Clinical phenotype of severe and moderate haemophilia: who should receive prophylaxis and what is the target trough level? Haemophilia. 2021;27:192-198.
Rattray B, Nugent DJ, Young G. Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia. Haemophilia. 2006;12:514-517.
Lobet S, Hermans C, Lambert C. Optimal management of hemophilic arthropathy and hematomas. J Blood Med. 2014;5:207-218.
Klamroth R, Gottstein S, Essers E, Landgraf H, Wilaschek M, Oldenburg J. Successful angiographic embolization of recurrent elbow and knee joint bleeds in seven patients with severe haemophilia. Haemophilia. 2009;15:247-252.
Galli E, Baques A, Moretti N, Candela M, Caviglia H. Hemophilic chronic synovitis: therapy of hemarthrosis using endovascular embolization of knee and elbow arteries. Cardiovasc Intervent Radiol. 2013;36:964-969.
Rivard GE. Chemical synovectomy in haemophilia: status and challenges. Haemophilia. 2001;7(Suppl 2):16-19.
Rodriguez-Merchan EC. Radiosynovectomy in haemophilia. Blood Rev. 2019;35:1-6.
Dunn AL, Busch MT, Wyly JB, Sullivan KM, Abshire TC. Arthroscopic synovectomy for hemophilic joint disease in a pediatric population. J Pediatr Orthop. 2004;24:414-426.
Wiedel JD. Arthroscopic synovectomy: state of the art. Haemophilia. 2002;8:372-374.
Mingo-Robinet J, Odent T, Elie C, et al. Open synovectomy of the ankle joint in young haemophiliacs: mid-term to long- term results of a single-centre series of 32 procedures. Haemophilia. 2015;21:e306-311.